Channel Therapeutics Corporation

CHRO · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$8-$7-$2-$1
Dep. & Amort.$1$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$4$0$0
Change in WC$0$2$1-$1
Other Non-Cash-$0$0-$0$1
Operating Cash Flow-$6-$1-$2-$2
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$1$0$0
Stock Issued$6$0$0$0
Stock Repurch.-$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$1$2
Financing Cash Flow$6$1$2$2
Forex Effect$0$0$0$0
Net Chg. in Cash$0$0$0$0
Supplemental Information
Beg. Cash$0$0$0$0
End Cash$1$0$0$0
Free Cash Flow-$6-$1-$2-$2